HEALTHY LIFESTYLE / RESEARCH PAPER
Changes in plasma concentration of cell-free DNA as a response to physical activity
More details
Hide details
1
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
2
3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague
3
Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
4
Department of Rehabilitation and Sports Medicine, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic
5
Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
6
3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Submission date: 2025-01-07
Final revision date: 2025-04-22
Acceptance date: 2025-06-01
Online publication date: 2025-06-22
Corresponding author
Michal Tomčík
Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Plasma concentrations of cell-free DNA (cfDNA) serve as markers of overtraining or muscle injury. We have examined, if nuclear (n) and mitochondrial (mt) cfDNA has the potential as a marker of muscle burden or damage.
Material and methods:
Ten healthy, physically active volunteers (6 females, aged 27.1±6.8 years) performed a downhill running test. Samples for cfnDNA and cfmtDNA analysis were collected before, 30 minutes, 1 hour, and 14 days after the downhill run. CfnDNA and cfmtDNA (two markers for both) were analysed using qPCR.
Results:
There was an extreme (~ 40-times) increase in cfnDNA at the 30-min time-point against the baseline (p<0.00001 for both markers), followed by a quick drop to baseline levels after 1 hour after the end of the downhill run for all subjects. In contrast, plasma levels of cfmtDNA did not increase significantly (p=0.27 and 0.12). It reflects the fact, that in 6 subjects, the pattern was similar as for cfnDNA but in 4 subjects rather a decrease of cfmtDNA concentration was observed at the 30-mi time-point. These differences correlate with age, BMI, and sex of the participants. Plasma cfnDNA significantly (p<0.01 for all) correlated with concentrations of muscle damage markers such as AST, ALT, and lactate dehydrogenase, and chemokines MIP-1α and IP-10 (positive). No homogenous correlation between cfmtDNA and biomarkers was detected.
Conclusions:
Our study confirms the extreme release and clearance of cfnDNA in physically active subjects after strenuous exercise. In contrast, the trajectory of cfmtDNA concentrations seems to have much higher inter-individual variability than cfnDNA concentrations.